title: Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab.
authors.affiliation: Division of immunology and allergy, department of medical specialties, Geneva university hospitals and school of medicine, rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland; Division of hematology, department of medical specialties, university hospitals and school of medicine, 1211 Geneva 14, Switzerland.
authors.forename: Federico
authors.initials: F
authors.lastname: Simonetta
authors.affiliation: Division of immunology and allergy, department of medical specialties, Geneva university hospitals and school of medicine, rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland.
authors.forename: Danièle
authors.initials: D
authors.lastname: Allali
authors.affiliation: Division of immunology and allergy, department of medical specialties, Geneva university hospitals and school of medicine, rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland.
authors.forename: Pascale
authors.initials: P
authors.lastname: Roux-Lombard
authors.affiliation: Division of immunology and allergy, department of medical specialties, Geneva university hospitals and school of medicine, rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland. Electronic address: carlo.chizzolini@unige.ch.
authors.forename: Carlo
authors.initials: C
authors.lastname: Chizzolini
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D000069283:Rituximab / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; D007166:Immunosuppressive Agents; D000069283:Rituximab; C511911:belimumab
keywords: BAFF; Belimumab; Lupus nephritis; Rituximab; SLE